New quality control system aims to reduce bleeding risks in heart patients
NCT ID NCT07354828
First seen Jan 22, 2026 · Last updated May 13, 2026 · Updated 15 times
Summary
This study involves 3,500 adults with acute coronary syndrome who have received a heart stent and are at high risk for bleeding. Researchers will test a new quality control system to see if it helps doctors better manage antiplatelet medications, balancing clot prevention with bleeding risk. The goal is to improve safety and personalize treatment, without changing standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
General Hospital of Northern Theater Command
Shenyang, Liaoning, 110000, China
Conditions
Explore the condition pages connected to this study.